141 related articles for article (PubMed ID: 30217622)
1. Histopathologic tumor regression grading in patients with gastric carcinoma submitted to neoadjuvant treatment: results of a Delphi survey.
Tsekrekos A; Detlefsen S; Riddell R; Conner J; Mastracci L; Sheahan K; Shetye J; Lundell L; Vieth M
Hum Pathol; 2019 Feb; 84():26-34. PubMed ID: 30217622
[TBL] [Abstract][Full Text] [Related]
2. Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus survey.
Saliba G; Detlefsen S; Carneiro F; Conner J; Dorer R; Fléjou JF; Hahn H; Kamaradova K; Mastracci L; Meijer SL; Sabo E; Sheahan K; Riddell R; Wang N; Yantiss RK; Lundell L; Low D; Vieth M; Klevebro F
Hum Pathol; 2021 Feb; 108():60-67. PubMed ID: 33221343
[TBL] [Abstract][Full Text] [Related]
3. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes.
Tsekrekos A; Vieth M; Ndegwa N; Bateman A; Flejou JF; Grabsch HI; Mastracci L; Meijer SL; Saragoni L; Sheahan K; Shetye J; Yantiss R; Lundell L; Detlefsen S
Hum Pathol; 2021 Oct; 116():94-101. PubMed ID: 34284051
[TBL] [Abstract][Full Text] [Related]
4. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.
Becker K; Mueller JD; Schulmacher C; Ott K; Fink U; Busch R; Böttcher K; Siewert JR; Höfler H
Cancer; 2003 Oct; 98(7):1521-30. PubMed ID: 14508841
[TBL] [Abstract][Full Text] [Related]
5. Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey.
Westerhoff M; Osecky M; Langer R
Mod Pathol; 2020 Apr; 33(4):676-689. PubMed ID: 31673084
[TBL] [Abstract][Full Text] [Related]
6. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
7. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
[TBL] [Abstract][Full Text] [Related]
8. Connection and distinction of tumor regression grading systems of gastrointestinal cancer.
Tong Y; Liu D; Zhang J
Pathol Res Pract; 2020 Sep; 216(9):153073. PubMed ID: 32825946
[TBL] [Abstract][Full Text] [Related]
9. Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches.
Karamitopoulou E; Thies S; Zlobec I; Ott K; Feith M; Slotta-Huspenina J; Lordick F; Becker K; Langer R
Am J Surg Pathol; 2014 Nov; 38(11):1551-6. PubMed ID: 25140894
[TBL] [Abstract][Full Text] [Related]
10. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H
Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451
[TBL] [Abstract][Full Text] [Related]
11. Management of the lymph nodes in penile cancer.
Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
[TBL] [Abstract][Full Text] [Related]
12. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer.
Martin-Romano P; Sola JJ; Diaz-Gonzalez JA; Chopitea A; Iragorri Y; Martínez-Regueira F; Ponz-Sarvise M; Arbea L; Subtil JC; Cano D; Ceniceros L; Legaspi J; Hernandez JL; Rodríguez J
Br J Cancer; 2016 Sep; 115(6):655-63. PubMed ID: 27537382
[TBL] [Abstract][Full Text] [Related]
13. Proposal for a multifactorial prognostic score that accurately classifies 3 groups of gastric carcinoma patients with different outcomes after neoadjuvant chemotherapy and surgery.
Becker K; Reim D; Novotny A; Zum Büschenfelde CM; Engel J; Friess H; Höfler H; Langer R
Ann Surg; 2012 Dec; 256(6):1002-7. PubMed ID: 22968067
[TBL] [Abstract][Full Text] [Related]
14. [Establishment and preliminary application of tissue response grading system following neoadjuvant chemotherapy].
Yang K; Zhang W; Chen X; Chen X; Liu K; Zhao L; Liu J; Wu B; Zhou Z; Hu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1032-1038. PubMed ID: 30269324
[TBL] [Abstract][Full Text] [Related]
15. Histopathological regression of gastric adenocarcinoma after neoadjuvant therapy: a critical review.
Neves Filho EH; de Sant'Ana RO; Nunes LV; Pires AP; da Cunha MD
APMIS; 2017 Feb; 125(2):79-84. PubMed ID: 28044374
[TBL] [Abstract][Full Text] [Related]
16. Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.
Langer R; Becker K
Virchows Arch; 2018 Feb; 472(2):175-186. PubMed ID: 28918544
[TBL] [Abstract][Full Text] [Related]
17. [Grading of tumor regression of gastrointestinal carcinomas after neoadjuvant therapy].
Liu D; Langer R
Pathologe; 2022 Feb; 43(1):51-56. PubMed ID: 34940918
[TBL] [Abstract][Full Text] [Related]
18. Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application.
Corben AD; Abi-Raad R; Popa I; Teo CH; Macklin EA; Koerner FC; Taghian AG; Brachtel EF
Arch Pathol Lab Med; 2013 Aug; 137(8):1074-82. PubMed ID: 23899063
[TBL] [Abstract][Full Text] [Related]
19. Histopathological factors predicting response to neoadjuvant therapy in gastric carcinoma.
Sánchez de Molina ML; Díaz Del Arco C; Vorwald P; García-Olmo D; Estrada L; Fernández-Aceñero MJ
Clin Transl Oncol; 2018 Feb; 20(2):253-257. PubMed ID: 28653276
[TBL] [Abstract][Full Text] [Related]
20. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Epstein JI; Amin MB; Reuter VE; Humphrey PA
Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
